GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kadimastem Ltd (XTAE:KDST) » Definitions » Equity-to-Asset

Kadimastem (XTAE:KDST) Equity-to-Asset

: -0.52 (As of Dec. 2023)
View and export this data going back to 2015. Start your Free Trial

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Kadimastem's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₪-4.36 Mil. Kadimastem's Total Assets for the quarter that ended in Dec. 2023 was ₪8.37 Mil.

The historical rank and industry rank for Kadimastem's Equity-to-Asset or its related term are showing as below:

XTAE:KDST' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.8   Med: -0.05   Max: 0.56
Current: -0.52

During the past 11 years, the highest Equity to Asset Ratio of Kadimastem was 0.56. The lowest was -1.80. And the median was -0.05.

XTAE:KDST's Equity-to-Asset is ranked worse than
89.66% of 1566 companies
in the Biotechnology industry
Industry Median: 0.66 vs XTAE:KDST: -0.52

Kadimastem Equity-to-Asset Historical Data

The historical data trend for Kadimastem's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kadimastem Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.65 -0.75 0.56 0.03 -0.52

Kadimastem Semi-Annual Data
Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.36 0.03 0.02 -0.52

Competitive Comparison

For the Biotechnology subindustry, Kadimastem's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kadimastem Equity-to-Asset Distribution

For the Biotechnology industry and Healthcare sector, Kadimastem's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Kadimastem's Equity-to-Asset falls into.



Kadimastem Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Kadimastem's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=-4.36/8.366
=

Kadimastem's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=-4.36/8.366
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kadimastem  (XTAE:KDST) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Kadimastem Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Kadimastem's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Kadimastem (XTAE:KDST) Business Description

Traded in Other Exchanges
Address
Pinchas Sapir 7, Weizmann Science Park, Nes-Ziona, ISR
Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.

Kadimastem (XTAE:KDST) Headlines

No Headlines